Newsletter Signup | Community
Two year outcomes reported in Lancet for patients with recurrent B-cell NHL treated with Yescarta CAR - T cells.
Dr. Jaglowski is a lymphoma expert and the medical director of Ohio State’s Stem Cell Transplant Program.
The Selective Inhibitor of Nuclear Export (SINE) Selinexor being developed as new treatment for lymphoma.
Answers to frequently asked questions about bone marrow aspiration and biopsy evaluation in lymphoma.
Checkmate 436 clinical trial reported at ASH suggests the targeted immunotherapy combination is very promising.
Novel Bispecific monoclonal antibody treatment appears promising for non-hodgkin lymphoma
Curious is others with celiac disease have develeoped lymphoma?
Long-Term Follow-Up Indicates Continued Improvement in Survival with Addition of Rituxan® to CHOP in NHL
